| For: | Waheed Y. Progress on global hepatitis elimination targets. World J Gastroenterol 2021; 27(47): 8199-8200 [PMID: 35068864 DOI: 10.3748/wjg.v27.i47.8199] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i47/8199.htm |
| Number | Citing Articles |
| 1 |
Jiyuan Ren, Ran Ji, Zimo Zhu, Xinxin Ren, Fanyun Kong, Hongjuan You, Xiaoge Gao, Feitong Wang, Renxian Tang, Xiangye Liu. Global, Regional and National Burden of Viral Hepatitis From 1990 to 2021 With Forecasts to 2046: Findings From the Global Burden of Disease Study 2021. Journal of Viral Hepatitis 2026; 33(11) doi: 10.1111/jvh.70236
|
| 2 |
Angela Domínguez, Ana Avellón, Victoria Hernando, Núria Soldevila, Eva Borràs, Ana Martínez, Conchita Izquierdo, Núria Torner, Carles Pericas, Cristina Rius, Pere Godoy. Hepatitis B Virus-Related Cirrhosis and Hepatocellular Carcinoma Hospital Discharge Rates from 2005 to 2021 in Spain: Impact of Universal Vaccination. Vaccines 2024; 12(11) doi: 10.3390/vaccines12111254
|
| 3 |
Yasir Waheed, Ranjit Sah, Khalid Muhammad. Recent Developments in Vaccines for Viral Diseases. Vaccines 2023; 11(2) doi: 10.3390/vaccines11020198
|
| 4 |
A. Russotto, C. Vicentini, L. Ferrigno, S. Crateri, R. Russo, M.E. Tosti, C.M. Zotti. Impact of the COVID-19 pandemic on the Italian national viral hepatitis surveillance: an interrupted time series analysis, 2006–2022. Public Health 2024; 232 doi: 10.1016/j.puhe.2024.04.006
|
| 5 |
Charles Berabose, Ralf Clemens, Tatiana De Noronha, Sue Ann Costa Clemens. Assessing the Status of and Impediments to Achieving the WHO Goal to Eliminate Viral Hepatitis B by 2030: A Scoping Review. Vaccines 2026; 14(10) doi: 10.3390/vaccines14100846
|
| 6 |
Anup S. Pathania, Sajad A. Bhat, Lukman A. Adepoju, Kusum K. Kharbanda, Natalia A. Osna. Hepatic Macrophages in Chronic Hepatitis B: Balancing Immunity and Pathology. Biology 2025; 15(1) doi: 10.3390/biology15010076
|
| 7 |
Sama Anvari, Keith Tsoi. Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?. Journal of Clinical Medicine 2024; 13(2) doi: 10.3390/jcm13020393
|
| 8 |
Md Razeen Ashraf Hussain, Lindsey Hiebert, Aya Sugiyama, Serge Ouoba, E Bunthen, Ko Ko, Tomoyuki Akita, Shuichi Kaneko, Tatsuya Kanto, John W. Ward, Junko Tanaka. Effect of COVID‐19 on hepatitis B and C virus countermeasures: Hepatologist responses from nationwide survey in Japan. Hepatology Research 2022; 52(11) doi: 10.1111/hepr.13819
|
| 9 |
Michele Pinon, Laura Giugliano, Francesca Rocchi, Mara Cananzi, Cinzia Auriti, Barbara Wade, Pier Luigi Calvo, Carlo Giaquinto, Giuseppe Indolfi. Inadequate Hospital Practices to Prevent Mother‐to‐Child Transmission of Hepatitis B Virus Infection. Journal of Pediatric Gastroenterology and Nutrition 2023; 76(6) doi: 10.1097/MPG.0000000000003765
|
| 10 |
Tony Sandset. ‘Ending AIDS’ between comparison and commensuration and the role of global health indicators. Global Public Health 2024; 19(1) doi: 10.1080/17441692.2024.2312435
|
| 11 |
Yasir Waheed, Sohail Naser Awan, Fahad Nasser Almajhdi, Bashir Ahmad, Abdul Sami, Dilber Uzun Ozsahin. Seroprevalence of hepatitis B and hepatitis C viral infections among refugees in Muzaffarabad, Pakistan. BMC Infectious Diseases 2025; 25(1) doi: 10.1186/s12879-025-11636-5
|
| 12 |
Mohd Amir F. Abdullah, Sarah M. McWhirter, Zucai Suo. Modulation of Kinase Activities In Vitro by Hepatitis C Virus Protease NS3/NS4A Mediated-Cleavage of Key Immune Modulator Kinases. Cells 2023; 12(3) doi: 10.3390/cells12030406
|
| 13 |
William C. W. Wong, Gifty Marley, Jingjing Li, Weihui Yan, Po-lin Chan, Joseph D. Tucker, Weiming Tang, Yuxin Ni, Dan Dan Cheng, Lou Cong, Wai-Kay Seto. A randomized controlled trial enhancing viral hepatitis testing in primary care via digital crowdsourced intervention. npj Digital Medicine 2022; 5(1) doi: 10.1038/s41746-022-00645-2
|